Melatonin induces neural SOD2 expression independent of the NF-kappaB pathway and improves the mitochondrial population and function in old mice

Journal of Pineal Research

Volumn 50, Issue 1, 2011, Pages 54-63

  García Macia, Marina ^a   Vega Naredo, Ignacio ^a   De Gonzalo Calvo, David ^a   Rodríguez González, Susana M ^a   Camello, Pedro J ^b   Camello Almaraz, Cristina ^b   Martín Cano, Francisco E ^b   Rodríguez Colunga, María J ^a   Pozo, María J ^b   Coto Montes, Ana M ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

aging; melatonin; mice; mitochondria; NF B; oxidative stress; SOD2

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; MELATONIN;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN; BRAIN NERVE CELL; CONTROLLED STUDY; FEMALE; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 78650113506     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2010.00809.x     Document Type: Article

References (56)

1. Harman D,. Aging: a theory based on free radicals and radiation biology. J Gerontol 1956; 11: 98-104.
2. Floyd RA,. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 1999; 222: 236-245.
3. Halliwell B, Gutteridge JMC,. Oxygen radicals and the central nervous system. Trends Nerosci 1985; 8: 22-39.
4. Sadrzadeh SMH, Eaton JW,. Hemoglobin-mediated oxidant damage in the central nervous system requires endogenous ascorbate. J Clin Invest 1988; 82: 1510-1515.
5. Caballero B, Vega-Naredo I, Sierra V, et al. Melatonin alters cell death processes in response to age-related oxidative stress in the brain of senescence-accelerated mice. J Pineal Res 2009; 46: 106-114.
6. Caballero B, Vega-Naredo I, Sierra V, et al. Favorable effects of a prolonged treatment with melatonin on the level of oxidative damage and neurodegeneration in senescence-accelerated mice. J Pineal Res 2008; 45: 302-311.
7. Pallas M, Casadesus G, Smith MA, et al. Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection. Curr Neurovasc Res 2009; 6: 70-81.
8. Tajes M, Gutierrez-Cuesta J, Ortuño-Sahagan D, Camins A, Pallas M,. Anti-aging properties of melatonin in a in vitro murine senescence model: involvement of the sirtuin 1 pathway. J Pineal Res 2009; 47: 228-237.
9. Irizarry MC, Kim TW, Mcnamara M, et al. Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system. J Neuropathol Exp Neurol 1996; 55: 889-895.
10. Kahle PJ, Neumann M, Ozmen L, et al. Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J Neurosci 2000; 20: 6365-6373.
11. Li W, Lesuisse C, Xu Y, et al. Stabilization of alpha-synuclein protein with aging and familial Parkinson's disease-linked A53T mutation. J Neurosci 2004; 24: 7400-7409.
12. Kim YA, Lim SY, Rhee SH, et al. Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in beta-amyloid-treated C6 glioma cells. Int J Mol Med 2006; 17: 1069-1075.
13. Kaplan B, Ratner V, Haas E,. Alpha-synuclein: its biological function and role in neurodegenerative diseases. J Mol Neurosci 2003; 20: 83-92.
14. Tan DX, Manchester LC, Terron ME, Flores LJ, Reiter RJ,. One molecule, many derivates: a never-ending interaction of melatonin with reactive oxygen and nitrogen species. J Pineal Res 2007; 42: 28-42.
15. Hardeland R, Tan DX, Reiter RJ,. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-126.
16. Reiter RJ, Acuña-Castroviejo D, Tan DX, Burkhardt S,. Free radical mediated molecular damage: mechanisms of melatonins protective actions in the central nervous system. Ann NY Acad Sci 2001; 939: 200-215.
17. Reiter RJ, Richardson BA, Johnson LY, Ferguson BN, Dinh DT,. Pineal melatonin rhythm: reduction in aging Syrian hamsters. Science 1980; 210: 1372-1373.
18. Poeggler B,. Melatonin, aging and age-related diseases: perspectives for prevention, intervention and therapy. Endocrine 2005; 27: 201-212.
19. Macmillan-Crow LA, Cruthirds DL,. Invited review: manganese superoxide dismutase in disease. Free Radic Res 2001; 34: 325-336.
20. Wallace DC,. Animal models for mitochondrial disease. Methods Mol Biol 2002; 197: 3-54.
21. Maity P, Bindu S, Dey S, et al. Melatonin reduces indomethacin-induced gastric mucosal cell apoptosis by preventing mitochondrial oxidative stress and the activation of mitochondrial pathway of apoptosis. J Pineal Res 2009; 46: 314-323.
22. Paradies G, Petrosillo G, Paradies V, Reiter RJ, Ruggiero FM,. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 48: 297-310.
23. Bradford MM,. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
24. Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-478.
25. Coto-Montes A, Hardeland R,. Antioxidative effects of melatonin in Drosophila melanogaster: antagonization of damage induced by the inhibition of catalase. J Pineal Res 1999; 27: 154-158.
26. Martin JP Jr, Dailey M, Sugarman E,. Negative and positive assays of superoxide dismutase based on hematoxylin autoxidation. Arch Biochem Biophys 1987; 255: 329-336.
27. ARNAO MB, CANO A, ACOSTA M,. The hydrophilic and lipophilic contribution to total antioxidant activity. Food Chem 2001; 73: 239-244.
28. Toescu EC, Verkhratsky A,. The importance of being subtle: small changes in calcium homeostasis control cognitive decline in normal aging. Aging Cell 2007; 6: 267-273.
29. Coore HG, Denton RM, Martin BR, et al. Regulation of adipose tissue pyruvate dehydrogenase by insulin and other hormones. Biochem J 1971; 125: 115-127.
30. Xiong J, Camello PJ, Verkhratsky A, et al. Mitochondrial polarisation status and [Ca2+]i signalling in rat cerebellar granule neurones aged in vitro. Neurobiol Aging 2004; 25: 349-359.
31. Harman D,. Role of free radicals in aging and disease. Ann N Y Acad Sci 1992; 673: 126-141. (Pubitemid 23057567)
32. Wang XL, Rainwater DL, Vandeberg JF, et al. Genetic contributions to plasma total antioxidant activity. Arterioscler Thromb Vasc Biol 2001; 21: 1190-1195.
33. Alvarez-Garcia O, Vega-Naredo I, Sierra V, et al. Elevated oxidative stress in the brain of senescence-accelerated mice at 5 months of age. Biogerontology 2006; 7: 43-52.
34. Gutierrez-Cuesta J, Sureda FX, Romeu M, et al. Chronic administration of melatonin reduces cerebral injury biomarkers in SAMP8. J Pineal Res 2007; 42: 394-402.
35. Waxman EA, Giasson BI,. Molecular mechanisms of alpha-synuclein neurodegeneration. Biochim Biophys Acta 2009; 1792: 616-624.
36. Selkoe DJ,. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 2004; 6: 1054-1061.
37. Aksenova MV, Aksenov MY, Mactutus CF, et al. Cell culture models of oxidative stress and injury in the central nervous system. Curr Neurovasc Res 2005; 2: 73-89.
38. Feng Z, Qin C, Chang Y, et al. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease. Free Radic Biol Med 2006; 40: 101-109.
39. Olcese JM, Cao C, Mori T, et al. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. J Pineal Res 2009; 47: 82-96.
40. Wallace DC,. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005; 39: 359-407.
41. Rodriguez MI, Escames G, Lopez LC, et al. Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice. Exp Gerontol 2008; 43: 749-756.
42. Nishikawa T, Takahashi JA, Fujibayashi Y, et al. An early stage mechanism of the age-associated mitochondrial dysfunction in the brain of SAMP8 mice; an age-associated neurodegeneration animal model. Neurosci Lett 1998; 254: 69-72.
43. Yarian CS, Rebrin I, Sohal RS,. Aconitase and ATP synthase are targets of malondialdehyde modification and undergo an age-related decrease in activity in mouse heart mitochondria. Biochem Biophys Res Commun 2005; 330: 151-156.
44. Toescu EC,. Normal brain ageing: models and mechanisms. Philos Trans R Soc Lond B Biol Sci 2005; 360: 2347-2354.
45. Leon J, Acuna-Castroviejo D, Sainz RM, et al. Melatonin and mitochondrial function. Life Sci 2004; 75: 765-790.
46. Gomez-Pinilla PJ, Gomez MF, Sward K, et al. Melatonin restores impaired contractility in aged guinea pig urinary bladder. J Pineal Res 2008; 44: 416-425.
47. Camello-Almaraz C, Gomez-Pinilla PJ, Pozo MJ, et al. Age-related alterations in Ca2+ signals and mitochondrial membrane potential in exocrine cells are prevented by melatonin. J Pineal Res 2008; 45: 191-198.
48. Kregel KC, Zhang HJ,. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 2007; 292: R18-R36.
49. Michiels C, Minet E, Mottet D, et al. Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes. Free Radic Biol Med 2002; 33: 1231-1242.
50. Zou Y, Jung KJ, Kim JW, et al. Alteration of soluble adhesion molecules during aging and their modulation by calorie restriction. FASEB J 2004; 18: 320-322.
51. Chung HY, Sung B, Jung KJ, et al. The molecular inflammatory process in aging. Antioxid Redox Signal 2006; 8: 572-581.
52. Libert S, Chao Y, Chu X, et al. Trade-offs between longevity and pathogen resistance in Drosophila melanogaster are mediated by NFkappaB signaling. Aging Cell 2006; 5: 533-543.
53. Delhalle S, Deregowski V, Benoit V, et al. NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis. Oncogene 2002; 21: 3917-3924.
54. Manna SK, Zhang HJ, Yan T, et al. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem 1998; 273: 13245-13254.
55. Manda K, Reiter RJ,. Melatonin maintains adult hippocampal neurogenesis and cognitive functions after irradiation. Prog Neurobiol 2010; 90: 60-68.
56. 2+-mediated permeability transition and beyond in rat brain astrocytes. J Pineal Res 2010; 48: 20-38.